Cianna Medical Inc.
Division of Merit Medical Systems Inc.
Latest From Cianna Medical Inc.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Medical device and diagnostic companies are developing innovative new products for women with breast cancer designed to facilitate earlier diagnosis, improve diagnostic accuracy, increase surgical precision, and enable the least invasive, most breast-conserving approach to breast cancer surgery. With the number of breast cancer cases in the US projected to increase dramatically by 2030, the success of these technologies depends on their ability to improve cosmetic results and survival rates while lowering overall health care costs.
A three-dimensional soft-tissue marker for use during breast cancer surgery is now in clinical use and has been shown to shorten the number of radiation treatments and spare dosing of normal tissue. The spiral BioZorb tissue marker from start-up Focal Therapeutics Inc. is used primarily during lumpectomy procedures and is placed following removal of the tumor and prior to radiation therapy.
The device industry is playing a pivotal role in the evolution toward a more personalized approach to breast cancer management, with ongoing advances in minimally invasive treatment systems, tumor characterization and breast imaging technologies adding to the momentum. In the years ahead, as the breast cancer toolbox expands, the watchword will be “choice,” with physicians and patients offered more treatment options, targeted to their specific needs and desires, than ever before.
- Implantable Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Merit Medical Systems Inc.
- Senior Management
Jill Anderson, Pres. & CEO
Gordon Busenbark, CFO
Eduardo Chi Sing, CTO
Mike Numamoto, VP, Mktg.
- Contact Info
Cianna Medical Inc.
Phone: (949) 360-0059
Aliso Viejo , CA 92656
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.